VSEE HEALTH Insider Aisiku Imoigele Files Form 4
| Field | Detail |
|---|---|
| Company | Aisiku Imoigele |
| Form Type | 4 |
| Filed Date | Mar 24, 2026 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: insider-filing, form-4, ownership-change
TL;DR
**VSEE HEALTH insider filed a Form 4, signaling a change in ownership.**
AI Summary
This Form 4 filing, dated March 24, 2026, reports a change in beneficial ownership for Aisiku Imoigele, an insider at VSEE HEALTH, INC. (CIK: 0001864531). While the filing indicates a change, the specific transaction details, such as shares bought or sold and their value, are not provided in the summary text. This matters to investors because insider transactions can signal management's confidence (or lack thereof) in the company's future, potentially influencing stock price movements.
Why It Matters
Insider transaction filings like this can offer clues about how company executives view their own stock, which can be a powerful signal for other investors.
Risk Assessment
Risk Level: low — This filing is purely administrative, reporting a change in ownership without detailing the transaction, thus posing minimal direct risk.
Analyst Insight
An investor should look for the full Form 4 document to understand the specific transaction (buy/sell, quantity, price) made by Aisiku Imoigele to gauge the potential implications for VSEE HEALTH, INC. stock.
Key Players & Entities
- Aisiku Imoigele (person) — Reporting person, an insider at VSEE HEALTH, INC.
- VSEE HEALTH, INC. (company) — The issuer of the securities, CIK: 0001864531
- 0002026054 (person) — CIK for Aisiku Imoigele
- 0001864531 (company) — CIK for VSEE HEALTH, INC.
- 2026-03-24 (date) — Filing Date and Accepted Date
- 2026-03-23 (date) — Period of Report
FAQ
Who is Aisiku Imoigele and what is their relationship to VSEE HEALTH, INC.?
Aisiku Imoigele is the 'Reporting' person in this Form 4 filing, indicating they are an insider (e.g., officer, director, or significant shareholder) of VSEE HEALTH, INC. (the 'Issuer').
What is the purpose of a Form 4 filing?
A Form 4, 'Statement of changes in beneficial ownership of securities,' is used to report changes in ownership of company stock by company insiders, such as officers, directors, and beneficial owners of more than 10% of a class of the company's equity securities.
When was this Form 4 filed and what period does it cover?
This Form 4 was filed and accepted on March 24, 2026, and the 'Period of Report' for the transactions covered is March 23, 2026.
What is the CIK number for VSEE HEALTH, INC.?
The CIK (Central Index Key) number for VSEE HEALTH, INC. is 0001864531, as stated in the filing.
Where is VSEE HEALTH, INC.'s business address located?
VSEE HEALTH, INC.'s business address is 2311 WEST MAIN STREET, HOUSTON TX 77098, according to the filing.
Filing Stats: 911 words · 4 min read · ~3 pages · Grade level 7.9 · Accepted 2026-03-24 16:35:09
Key Financial Figures
- $0.0001 — ) or (D) Price Common Stock, par value $0.0001 per share 03/23/2026 A 128,342 A $ 0.37
Filing Documents
- ownership.html (4)
- ownership.xml (4) — 10KB
- 0001185185-26-001038.txt ( ) — 11KB
From the Filing
SEC FORM 4 SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10. 1. Name and Address of Reporting Person * Aisiku Imoigele (Last) (First) (Middle) C/O VSEE HEALTH, INC. 980 N FEDERAL HWY #304 (Street) BOCA RATON FLORIDA 33432 (City) (State) (Zip) UNITED STATES (Country) 2. Issuer Name and Ticker or Trading Symbol VSEE HEALTH, INC. [ VSEE ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X Director 10% Owner X Officer (give title below) Other (specify below) Co-Chief Executive Officer 2a. Foreign Trading Symbol 3. Date of Earliest Transaction (Month/Day/Year) 03/23/2026 6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person 4. If Amendment, Date of Original Filed (Month/Day/Year) Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock, par value $0.0001 per share 03/23/2026 A 128,342 A $ 0.37 (1) 3,545,031 D Common Stock, par value $0.0001 per share 03/23/2026 A 78,689 A $ 0.61 (2) 3,416,689 D Common Stock, par value $0.0001 per share 03/23/2026 A 41,379 A $ 1.16 (3) 3,338,000 D Common Stock, par value $0.0001 per share 03/23/2026 A 40,000 A $ 1.2 (4) 3,296,621 D Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Explanation of Responses: 1. Reflects shares of common stock issued to the reporting person under the issuer's 2024 Incentive Plan (the "Incentive Plan") as the quarterly equity award owed by the issuer to the reporting person for the quarter ended December 31, 2025 pursuant to the Executive Employment Agreement between the reporting person and the issuer dated December 10, 2025 (the "Employment Agreement"). The number of shares issued to the reporting person is based on the closing price of the common stock on December 31, 2025. 2. Reflects shares of common stock issued to the reporting person under the Incentive Plan as the quarterly equity award owed by the issuer to the reporting person for the quarter ended September 30, 2025 pursuant to the Employment Agreement. The number of shares issued to the reporting person is based on the closing price of the common stock on September 30, 2025. 3. Reflects shares of common stock issued to the reporting person under the Incentive Plan as the quarterly equity award owed by the issuer to the reporting person for the quarter ended June 30, 2025 pursuant to the Employment Agreement. The number of shares issued to the reporting person is based on the closing price of the common stock on June 30, 2025. 4. Reflects shares of common stock issued to the reporting person under the Incentive Plan as the quarterly equity award owed by the issuer to the reporting person for the quarter ended March 31, 2025 pursuant to the Employment Agreement. The number of shares issued to the reporting person is based on the closing price of the common stock on March 31, 2025. /s/ Imoigele Aisiku 03/24/2026 ** Signature of Reporting Person D